Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy
Abstract
We investigate whether longitudinal callosal atrophy could predict conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2016
- Source ID
- 10.1016/j.dadm.2016.01.003
Entities
People
- Alvin H. Bachman
- Babak A. Ardekani
- Donghyeon Yu
- Johan Lim
- Sang Han Lee
- The Alzheimer’s Disease Neuroimaging Initiative*
Organizations
- BioClinica
- Canadian Institutes of Health Research
- Chiron Corporation
- Eli Lilly and Company
- GE HealthCare
- Keimyung University
- Laboratoires Servier
- Merck & Co.
- Nathan Kline Institute for Psychiatric Research
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- New York University
- Norman Cousins Center for Psychoneuroimmunology
- Pfizer
- Roche (United States)
- Seoul National University
- Takeda Pharmaceutical Company
- United States Department of Defense